Advertisement
U.S. Markets closed

Venture Life Group plc (VLG.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
40.50-1.00 (-2.41%)
At close: 03:54PM GMT

Venture Life Group plc

12 The Courtyard
Eastern Road
Bracknell RG12 2XB
United Kingdom
44 13 4457 8004
https://www.venture-life.com

Sector(s)Consumer Defensive
IndustryHousehold & Personal Products
Full Time Employees165

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeremy Anthony Philip Randall ACACo-Founder, CEO & Executive Director495.99kN/A1964
Mr. Daniel James WellsCFO & Director344.02kN/A1987
Mr. Lodovico Gianluca BragutiChief Manufacturing Officer & Executive Director424.66kN/A1960
Ben ColmanDirector of Corporate DevelopmentN/AN/AN/A
Mr. Domenico BarbaroHead of ProcurementN/AN/AN/A
Mr. Ennio SchiroHead of ESG StrategyN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Corporate Governance

Venture Life Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.